Icon Plc Stock Symbol. Iclr) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries and government and public health organisations, today announced it has been awarded best clinical research organisation (cro) at the vaccine industry. Click the insert data icon for a list of available fields.
While the vast majority of its revenue comes from clinical research, icon also offers ancillary services such as. Consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Peers and a company profile.
Nasdaq global select | jul 21, 2020, 11:34 am edt iclr:us $ 193.15.
The investor relations website contains information about icon plc's business for stockholders, potential investors, and financial analysts. Find the latest earnings report date for icon plc ordinary shares (iclr) at nasdaq.com. Jan 13, 2020 8:30 am est. Business description icon plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries.
